StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) PT Raised to $38 at Leerink Partners
January 31, 2018 7:47 AM
Leerink Partners raised its price target on Pfizer (NYSE: PFE) to $38.00 (from $35.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Pfizer (PFE) PT Raised to $39 at Credit Suisse
January 31, 2018 10:22 AM
Pfizer (PFE) PT Raised to $42 at BofA/Merrill Lynch
January 31, 2018 9:56 AM
Pfizer (PFE) PT Raised to $43 at Morgan Stanley
January 31, 2018 9:47 AM
Pfizer (PFE) PT Raised to $42 at UBS
January 31, 2018 9:37 AM
Pfizer (PFE) PT Raised to $44 at Bernstein on 4Q Beat; 'Lower than Expected Tax Rate... Decent 2018 Guidance'
January 31, 2018 8:58 AM
Pfizer (PFE) PT Raised to $42 at Deutsche Bank Following 4Q
January 31, 2018 7:39 AM
Pfizer (PFE) PT Raised to $43 at Morgan Stanley
January 31, 2018 7:29 AM
Pfizer (PFE) PT Raised to $43 at BMO Capital
January 31, 2018 5:01 AM
Pfizer (PFE) PT Raised to $41 at Barclays
January 31, 2018 4:05 AM
AbbVie (ABBV), Eli Lilly (LLY) More Vulnerable Than Other Drug Cos. on Amazon Entry - BMO
January 30, 2018 3:01 PM
Pfizer (PFE) Not Hungry for a Large Deal - BMO
January 30, 2018 12:54 PM
